A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence
A novel idea is introduced regarding the statistical comparisons of endpoints in clinical trials. Currently, the (dis)similarity of measured endpoints is not assessed. Instead, statistical analysis is directly applied, which can lead to multiplicity issues, reduced statistical power, and the recruit...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2024-06-01
|
| Rangatū: | Journal of Cardiovascular Development and Disease |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/2308-3425/11/7/185 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|